{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:00:30Z","timestamp":1788969630877,"version":"build-2803163510"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Fecal calprotectin is a reliable surrogate marker for disease activity in ulcerative colitis. However, there are no consensus cutoff values for histoendoscopic remission. This study aimed to correlate fecal calprotectin with Mayo endoscopic score and histological disease activity (Geboes score) for ulcerative colitis patients in clinical remission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Prospective study including adult ulcerative colitis patients in clinical remission or disease relapse, undergoing endoscopy for disease activity or dysplasia surveillance at an inflammatory bowel disease center between 2013 and 2020. Fecal calprotectin was collected before bowel preparation and Mayo endoscopic score was documented during colonoscopy. Biopsies were taken throughout the colon and histological activity was assessed using Geboes score by a blinded expert gastrointestinal pathologist.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Two hundred fifty-three patients were included, 117 (46%) were male (mean age of 38.2 years\u2014standard deviation \u00b1 24.8). A fecal calprotectin \u2265 123 \u03bcg\/g predicts Mayo endoscopic score &amp;gt; 0 (58% sensitivity and 70% specificity), also aiding to differentiate Mayo endoscopic score 0 from 1 (61% sensitivity and 70% specificity). A fecal calprotectin \u2265 80 \u03bcg\/g identified histological disease activity using Geboes score &amp;gt; 3.1 in patients with clinical remission (64.7% sensitivity, 58.7% specificity). Using Geboes score &amp;gt; 2, a fecal calprotectin \u2265 50 \u03bcg\/g, is the most clinically relevant to identify patients in clinical remission with active histologic inflammation (49.6% sensitivity, 41.6% specificity).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Fecal calprotectin correlates with endoscopic and histologic disease activity and can be used as a surrogate marker for disease activity. Our study prospectively demonstrated optimal cutoff values to discriminate histoendoscopic remission.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ibd\/izaf008","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T15:19:52Z","timestamp":1736349592000},"page":"2977-2985","source":"Crossref","is-referenced-by-count":2,"title":["Defining Fecal Calprotectin Cutoffs That Predict Endoscopic and Histologic Remission in Patients With Ulcerative Colitis"],"prefix":"10.1093","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1963-7848","authenticated-orcid":false,"given":"Gustavo","family":"Dr\u00fcgg Hahn","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, McGill University , Montreal, QC ,","place":["Canada"]},{"name":"Graduate Program in Gastroenterology and Hepatology, Universidade Federal do Rio Grande do Sul , Porto Alegre ,","place":["Brazil"]},{"name":"Department of Gastroenterology, Hospital de Cl\u00ednicas de Porto Alegre , Porto Alegre ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Laszlo","family":"Lakatos","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, McGill University , Montreal, QC ,","place":["Canada"]},{"name":"First Department of Medicine, Semmelweis University , Budapest ,","place":["Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Maedler-Kron","sequence":"additional","affiliation":[{"name":"Department of Pathology, McGill University Health Center , Montreal, QC ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Marcus","sequence":"additional","affiliation":[{"name":"Department of Pathology, McGill University Health Center , Montreal, QC ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6869-0982","authenticated-orcid":false,"given":"Waqqas","family":"Afif","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, McGill University , Montreal, QC ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9625-3437","authenticated-orcid":false,"given":"Gary","family":"Wild","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, McGill University , Montreal, QC ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Bitton","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, McGill University , Montreal, QC ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Flores","sequence":"additional","affiliation":[{"name":"Diimuno - Center for treatment of Inflammatory Bowel Diseases and Immune-mediated Diseases , Porto Alegre, RS ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8206-9121","authenticated-orcid":false,"given":"Carlos Fernando","family":"de Magalh\u00e3es Francesconi","sequence":"additional","affiliation":[{"name":"Graduate Program in Gastroenterology and Hepatology, Universidade Federal do Rio Grande do Sul , Porto Alegre ,","place":["Brazil"]},{"name":"Department of Gastroenterology, Hospital de Cl\u00ednicas de Porto Alegre , Porto Alegre ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2610-1910","authenticated-orcid":false,"given":"Talat","family":"Bessissow","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, McGill University , Montreal, QC ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,19]]},"reference":[{"issue":"4","key":"2025112116472417500_CIT0001","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1136\/gut.2005.088732","article-title":"Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target","volume":"56","author":"Rutgeerts","year":"2007","journal-title":"Gut."},{"issue":"2","key":"2025112116472417500_CIT0002","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1053\/j.gastro.2007.05.051","article-title":"Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort","volume":"133","author":"Fr\u00f8slie","year":"2007","journal-title":"Gastroenterology."},{"issue":"2","key":"2025112116472417500_CIT0003","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s40265-016-0676-y","article-title":"Mucosal healing in ulcerative colitis: a comprehensive review","volume":"77","author":"Boal Carvalho","year":"2017","journal-title":"Drugs."},{"issue":"1","key":"2025112116472417500_CIT0004","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/jgh.13061","article-title":"Fecal calprotectin is a clinically relevant biomarker of mucosal healing in patients with quiescent ulcerative colitis","volume":"31","author":"Yamaguchi","year":"2016","journal-title":"J Gastroenterol Hepatol."},{"issue":"11","key":"2025112116472417500_CIT0005","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1038\/ajg.2012.301","article-title":"Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healing","volume":"107","author":"Bessissow","year":"2012","journal-title":"Am J Gastroenterol."},{"issue":"8","key":"2025112116472417500_CIT0006","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.cgh.2013.02.030","article-title":"Histologic markers of inflammation in patients with ulcerative colitis in clinical remission","volume":"11","author":"Rosenberg","year":"2013","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"11","key":"2025112116472417500_CIT0007","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/1751-2980.12546","article-title":"Clinical, endoscopic and histological correlation and measures of association in ulcerative colitis","volume":"18","author":"Flux\u00e1","year":"2017","journal-title":"J Dig Dis."},{"issue":"6","key":"2025112116472417500_CIT0008","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.gie.2018.08.018","article-title":"The emerging role of histologic disease activity assessment in ulcerative colitis","volume":"88","author":"Pai","year":"2018","journal-title":"Gastrointest Endosc."},{"issue":"1","key":"2025112116472417500_CIT0009","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11894-015-0477-6","article-title":"Understanding endoscopic disease activity in IBD: how to incorporate it into practice","volume":"18","author":"Christensen","year":"2016","journal-title":"Curr Gastroenterol Rep."},{"issue":"9","key":"2025112116472417500_CIT0010","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/1751-2980.12540","article-title":"Potential roles of neutrophils in regulating intestinal mucosal inflammation of inflammatory bowel disease","volume":"18","author":"Zhou","year":"2017","journal-title":"J Dig Dis."},{"issue":"0065-2423","key":"2025112116472417500_CIT0011","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/bs.acc.2018.07.005","article-title":"Fecal calprotectin","volume":"87","author":"Ayling","year":"2018","journal-title":"Adv Clin Chem."},{"issue":"12","key":"2025112116472417500_CIT0012","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1002\/ibd.22917","article-title":"Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease","volume":"18","author":"D\u02bcHaens","year":"2012","journal-title":"Inflamm Bowel Dis."},{"issue":"5","key":"2025112116472417500_CIT0013","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1097\/MIB.0b013e3182802b6e","article-title":"A new rapid quantitative test for fecal calprotectin predicts endoscopic activity in ulcerative colitis","volume":"19","author":"Lobat\u00f3n","year":"2013","journal-title":"Inflamm Bowel Dis."},{"issue":"1","key":"2025112116472417500_CIT0014","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1189\/jlb.70.1.130","article-title":"Mechanism of extracellular release of human neutrophil calprotectin complex","volume":"70","author":"Voganatsi","year":"2001","journal-title":"J Leukoc Biol."},{"issue":"8","key":"2025112116472417500_CIT0015","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1002\/ibd.20933","article-title":"Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse","volume":"15","author":"Gisbert","year":"2009","journal-title":"Inflamm Bowel Dis."},{"issue":"3","key":"2025112116472417500_CIT0016","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1136\/gut.2004.043406","article-title":"Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn\u2019s disease","volume":"54","author":"Costa","year":"2005","journal-title":"Gut."},{"issue":"5","key":"2025112116472417500_CIT0017","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology."},{"issue":"9","key":"2025112116472417500_CIT0018","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1515\/cclm-2016-0796","article-title":"Analytical and diagnostic performance of two automated fecal calprotectin immunoassays for detection of inflammatory bowel disease","volume":"55","author":"De Sloovere","year":"2017","journal-title":"Clin Chem Lab Med."},{"issue":"12","key":"2025112116472417500_CIT0019","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1002\/ibd.20520","article-title":"Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis","volume":"14","author":"Lewis","year":"2008","journal-title":"Inflamm Bowel Dis."},{"issue":"3","key":"2025112116472417500_CIT0020","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/gut.47.3.404","article-title":"A reproducible grading scale for histological assessment of inflammation in ulcerative colitis","volume":"47","author":"Geboes","year":"2000","journal-title":"Gut."},{"issue":"5","key":"2025112116472417500_CIT0021","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1007\/s10620-018-4980-0","article-title":"Fecal calprotectin in assessing endoscopic and histological remission in patients with ulcerative colitis","volume":"63","author":"Mak","year":"2018","journal-title":"Dig Dis Sci."},{"issue":"5","key":"2025112116472417500_CIT0022","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/ibd\/izaa163","article-title":"Fecal calprotectin thresholds to predict endoscopic remission using advanced optical enhancement techniques and histological remission in IBD patients","volume":"27","author":"Cannatelli","year":"2021","journal-title":"Inflamm Bowel Dis."},{"issue":"7","key":"2025112116472417500_CIT0023","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/apt.15662","article-title":"Review article: faecal calprotectin and histologic remission in ulcerative colitis","volume":"51","author":"D\u2019Amico","year":"2020","journal-title":"Aliment Pharmacol Ther."},{"issue":"1","key":"2025112116472417500_CIT0024","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/ecco-jcc\/jjz107","article-title":"Faecal calprotectin predicts endoscopic and histological activity in clinically quiescent ulcerative colitis","volume":"14","author":"Hart","year":"2020","journal-title":"J Crohns Colitis."},{"issue":"12","key":"2025112116472417500_CIT0025","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1093\/ibd\/izae005","article-title":"Diagnostic performance of a fecal calprotectin assay as a biomarker for Mayo endoscopic subscore in ulcerative colitis: result from a tertiary referral center","volume":"30","author":"Suttichaimongkol","year":"2024","journal-title":"Inflamm Bowel Dis."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izaf008\/64325033\/izaf008.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/11\/2977\/64325033\/izaf008.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/11\/2977\/64325033\/izaf008.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T21:47:28Z","timestamp":1763761648000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/31\/11\/2977\/8258589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":25,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,9,19]]},"published-print":{"date-parts":[[2025,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izaf008","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,9,19]]}}}